adamantane has been researched along with Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balkovec, JM; Chen, HY; Cheng, K; Hermanowski-Vosatka, A; Hernandez, M; Koo, GC; Le Grand, CB; Li, Z; Metzger, JM; Mundt, SS; Noonan, H; Nunes, CN; Olson, SH; Pikounis, B; Ren, N; Robertson, N; Schaeffer, JM; Shah, K; Springer, MS; Strack, AM; Strowski, M; Thieringer, R; Wright, SD; Wu, K; Wu, T; Xiao, J; Zhang, BB | 1 |
| Day, CE; Phillips, WA; Schurr, PE | 1 |
2 other study(ies) available for adamantane and Arteriosclerosis
| Article | Year |
|---|---|
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adamantane; Animals; Aorta; Arteriosclerosis; Azepines; Blood Glucose; Cortisone; Diet, Atherogenic; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Fatty Acids; Hydrocortisone; Insulin; Insulin Resistance; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Syndrome; Triazoles; Triglycerides | 2005 |
Animal models for an integrated approach to the pharmacologic control of atherosclerosis.
Topics: Adamantane; Aniline Compounds; Animals; Arteriosclerosis; Clofibrate; Coturnix; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Haplorhini; Humans; Hypolipidemic Agents; Macaca fascicularis; Male; Mitotane; Piperidines; Rats; Terminology as Topic | 1979 |